The role of neuropeptide somatostatin in the brain and its application in treating neurological disorders
Authors:
Open Access
- 19 March 2021
- journal article
- review article
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 53 (3) , 328-338
Abstract
Somatostatin (SST) is a well-known neuropeptide that is expressed throughout the brain. In the cortex, SST is expressed in a subset of GABAergic neurons and is known as a protein marker of inhibitory interneurons. Recent studies have identified the key functions of SST in modulating cortical circuits in the brain and cognitive function. Furthermore, reduced expression of SST is a hallmark of various neurological disorders, including Alzheimer’s disease and depression. In this review, we summarize the current knowledge on SST expression and function in the brain. In particular, we describe the physiological roles of SST-positive interneurons in the cortex. We further describe the causal relationship between pathophysiological changes in SST function and various neurological disorders, such as Alzheimer’s disease. Finally, we discuss potential treatments and possibility of novel drug developments for neurological disorders based on the current knowledge on the function of SST and SST analogs in the brain derived from experimental and clinical studies.Keywords
Funding Information
- National Research Foundation of Korea (2017R1A2B3008270, 2017M3C7A1030798, 2018R1A4A1025616, 2020R1I1A1A0107412511)
- KAIST (Global Singularity Program for 2020)
This publication has 99 references indexed in Scilit:
- A neural circuit for spatial summation in visual cortexNature, 2012
- Viral disruption of the blood–brain barrierTrends in Microbiology, 2012
- Large-Scale Cellular-Resolution Gene Profiling in Human Neocortex Reveals Species-Specific Molecular SignaturesCell, 2012
- How Inhibition Shapes Cortical ActivityNeuron, 2011
- Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depressionMolecular Psychiatry, 2011
- Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophreniaTrends in Pharmacological Sciences, 2011
- Hippocampal interneurons are abnormal in schizophreniaSchizophrenia Research, 2011
- Reduced somatostatin in subgenual anterior cingulate cortex in major depressionNeurobiology of Disease, 2011
- Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortexNature Reviews Neuroscience, 2008
- The Corticosteroid Receptor Hypothesis of DepressionNeuropsychopharmacology, 2000